| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Beijing Aosaikang Pharmaceutical Co. Ltd (SHE: 002755)
002755 Technical Analysis
5
| As on 17th Nov 2025 002755 STOCK Price closed @ 18.59 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 12.87 & Strong Buy for SHORT-TERM with Stoploss of 10.01 we also expect STOCK to react on Following IMPORTANT LEVELS. |
002755STOCK Price
| Open | 19.83 | Change | Price | % |
| High | 19.87 | 1 Day | -1.10 | -5.59 |
| Low | 18.47 | 1 Week | -0.17 | -0.91 |
| Close | 18.59 | 1 Month | -2.36 | -11.26 |
| Volume | 26008075 | 1 Year | 7.76 | 71.65 |
| 52 Week High 28.40 | 52 Week Low 9.13 | ||||
SHE China Most Active Stocks
| 300058 | 8.69 | 12.42% |
| 000564 | 2.84 | 1.07% |
| 000981 | 3.53 | 0.57% |
| 002506 | 3.14 | -2.48% |
| 000620 | 3.83 | 10.06% |
| 000572 | 10.94 | 0.00% |
| 002426 | 4.06 | 7.41% |
| 002146 | 1.88 | -3.59% |
| 002131 | 5.09 | 4.73% |
| 000725 | 3.96 | -1.00% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
| 002755 Daily Charts |
002755 Intraday Charts |
Whats New @ Bazaartrend |
002755 Free Analysis |
|
|
002755 Important Levels Intraday
| RESISTANCE | 21.29 |
| RESISTANCE | 20.42 |
| RESISTANCE | 19.89 |
| RESISTANCE | 19.35 |
| SUPPORT | 17.83 |
| SUPPORT | 17.29 |
| SUPPORT | 16.76 |
| SUPPORT | 15.89 |
002755 Forecast November 2025
| 4th UP Forecast | 22.04 |
| 3rd UP Forecast | 20.93 |
| 2nd UP Forecast | 20.25 |
| 1st UP Forecast | 19.57 |
| 1st DOWN Forecast | 17.61 |
| 2nd DOWN Forecast | 16.93 |
| 3rd DOWN Forecast | 16.25 |
| 4th DOWN Forecast | 15.14 |
002755 Weekly Forecast
| 4th UP Forecast | 20.36 |
| 3rd UP Forecast | 19.79 |
| 2nd UP Forecast | 19.44 |
| 1st UP Forecast | 19.09 |
| 1st DOWN Forecast | 18.09 |
| 2nd DOWN Forecast | 17.74 |
| 3rd DOWN Forecast | 17.39 |
| 4th DOWN Forecast | 16.82 |
002755 Forecast2025
| 4th UP Forecast | 57.07 |
| 3rd UP Forecast | 44.73 |
| 2nd UP Forecast | 37.1 |
| 1st UP Forecast | 29.47 |
| 1st DOWN Forecast | 7.71 |
| 2nd DOWN Forecast | 0.08 |
| 3rd DOWN Forecast | -7.55 |
| 4th DOWN Forecast | -19.89 |
Beijing Aosaikang Pharmaceutical Co. Ltd ( SHE China Symbol : 002755 )
Sector : Industrials And Other Stocks in Same Sector
Sector : Industrials And Other Stocks in Same Sector
002755 Other Details
| Segment | EQ | |
| Market Capital | 11360677888.00 | |
| Sector | Industrials | |
| Industry | Engineering & Construction | |
| Offical website | > echo $website ; ?> | |
002755 Address
![]() |
||
002755 Latest News
002755 Business Profile
Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in digestive, oncology, antibiotic, and other areas. Beijing Aosaikang Pharmaceutical Co., Ltd. was founded in 2003 and is based in Nanjing, China. Address: Jiangning Science Park, Nanjing, China, 211112
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

